- Special populations: Getting effective medicines to children in a timely manner - an interview with Koen Norga, Chair of EMA's Paediatric Committee
- Special populations: Managing the supply of unlicensed medicines to patients in the UK
- Feature article: Considerations for virtualising clinical trials in the midst of COVID-19
- Feature article: An overview of the CMDv's pilot part II harmonisation project
- Feature article: ICH Q12 - how it impacts the management of your CMC post-approval changes
Click here to access the complete July/August 2020 issue digitally, or use the links below for this and past issues going back to 2015.
Note: to access members-only content, you must be logged in to the site with your TOPRA Member account.